Polypharmacology for all therapeutic aeras using nano-drug delivery systems
Schizophrenia / Psychosis
Crohn's disease
F2i is a first-in-class, non-kinase, protein-protein interaction inhibitor of aberrant fibroblast growth factor signalling pathway in invasive cancers
